Abstract
A decrease in the birth rate and an increase in maternal age have been showed in the last decades. Alternatively, advances in assisted reproductive technology (ART) allows pregnancy at any age, and we face new ethical and health challenges regarding the question of what is the limit for a woman to become pregnant. Now that ARTs are common throughout the world, the medical, legal, moral, and ethical debates unleashed since their inception has been globalized. On the other hand, genetic counseling is a communication process that deals with the human problems associated with the occurrence, or the risk of occurrence, of a genetic disorder in a family. It is based on medical, reproductive, and family history and must always be carried out. In assisted reproduction, risk assessment includes not only the embryo and the fetus but also the parent itself.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liu XJ. Targeting oocyte maturation to improve fertility in older women. Cell Tissue Res. 2016;363(1):57–68.
Wilding M. Potential long-term risks associated with maternal aging (the role of the mitochondria). Fertil Steril. 2015;103(6):1397–401.
Yoldemir T. Fertility in midlife women. Climacteric. 2016;19(3):240–6.
Sauer MV. Reproduction at an advanced maternal age and maternal health. Fertil Steril. 2015;103(5):1136–43.
Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Reproductive Endocrinology and Infertility. Optimizing natural fertility: a committee opinion. Fertil Steril. 2013;100(3):631–7.
Braverman AM. Old, older and too old: age limits for medically assisted fatherhood? Fertil Steril. 2017;107(2):329–33.
MacArthur T, Bachmann G, Ayers C. Menopausal women requesting egg/embryo donation: examining health screening guidelines for assisted reproductive technology. Menopause. 2016;23(7):799–802.
van den Akker O. A review of family donor constructs: current research and future directions. Hum Reprod Update. 2006;12(2):91–101.
American Society of Human Genetics. Genetic counseling. Am J Hum Genet. 1975;27:240–2.
Harper JC, Aittomäki K, Borry P, Cornel MC, de Wert G, Dondorp W, Geraedts J, Gianaroli L, Ketterson K, Liebaers I, Lundin K, Mertes H, Morris M, Pennings G, Sermon K, Spits C, Soini S, van Montfoort APA, Veiga A, Vermeesch JR, Viville S, Macek M Jr. Recent developments in genetics and medically assisted reproduction: from research to clinical applications. Eur J Hum Genet. 2018;26:12–33. https://doi.org/10.1038/s41431-017-0016-z.
Kuznyetsov V, Madjunkova S, Antes R, Abramov R, Motamedi G, Ibarrientos Z, et al. Evaluation of a novel non-invasive preimplantation genetic screening approach. PLoS One. 2018;13(5):e0197262.
Maxwell SM, Colls P, Hodes-Wertz B, et al. Why do euploid embryos miscarry? A case-control study comparing the rate of aneuploidy within presumed euploid embryos that resulted in miscarriage or live birth using next-generation sequencing. Fertil Steril. 2016;106:1414–19.e5.
Hoeijmakers L, Kempe H, Verschure PJ. Epigenetic imprinting during assisted reproductive technologies: the effect of temporal and cumulative fluctuations in methionine cycling on the DNA methylation state: susceptibility to epigenetic defects in art. Mol Reprod Dev. 2016;83:94–107.
Marshall KL, Rivera RM. The effects of superovulation and reproductive aging on the epigenome of the oocyte and embryo. Mol Reprod Dev. 2018;85:90–105. https://doi.org/10.1002/mrd.22951
Koscinski I, Merten M, Kazdar N, Guéant J-L. Culture conditions for gametes and embryos: which culture medium? Which impact on newborn? Gynécol Obstét Fertil Sénol. 2018;46:474–80.
Ventura-Juncá P, Irarrázaval I, Rolle AJ, Gutiérrez JI, Moreno RD, Santos MJ. In vitro fertilization (IVF) in mammals: epigenetic and developmental alterations. Scientific and bioethical implications for IVF in humans. Biol Res. 2015;48:68. https://doi.org/10.1186/s40659-015-0059-y.
Uk A, Collardeau-Frachon S, Quentin Scanvion LM, Amarf E. Assisted reproductive technologies and imprinting disorders: results of a study from a French congenital malformations registry. Eur J Med Genet. 2018;61(9):518–23. https://doi.org/10.1016/j.ejmg.2018.05.017.
Miranda RC, Salem NA, Fincher AS, Mahnke AH, Burrowes SG. Epigenetic mechanisms and inheritance of acquired susceptibility to disease. In: Medical epigenetics; 2016. p. 531–52. https://doi.org/10.1016/B978-0-12-803239-8.00030-2.
Letao Chen B, Yang T, Zheng Z, Hong Y, Wang H, Qin J. Birth prevalence of congenital malformations in singleton pregnancies resulting from in vitro fertilization/intracytoplasmic sperm injection worldwide: a systematic review and meta-analysis. Arch Gynecol Obstet. 2018;297:1115–30. https://doi.org/10.1007/s00404-018-4712-x.
Giorgione V, Parazzini F, Fesslova V, Cipriani S, Candiani M, Inversetti A, Sigismondi C, Tiberio F, Cavoretto P. Congenital heart defects in IVF/ICSI pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51:33–42. https://doi.org/10.1002/uog.18932.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–72.
Pasi CE, Dereli-O A, Negrini S, Friedli M, Fragola G, Lombardo A, Van Houwe G, Naldini L, Casola S, Testa G, Trono D, Pelicci PG, Halazonetis TD. Genomic instability in induced stem cells. Cell Death Differ. 2011;18:745–53.
Spits C, Mateizel I, Geens M, et al. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol. 2008;26:1361–3.
Van Haute L, Spits C, Geens M, Seneca S, Sermon K. Human embryonic stem cells commonly display large mitochondrial DNA deletions. Nat Biotechnol. 2013;31:20–3.
Amps K, Andrews PW, Anyfantis G, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011;29:1132–44.
Greenfield A, Braude P, Flinter F, Lovell-Badge R, Ogilvie C, Perry ACF. Assisted reproductive technologies to prevent human mitochondrial disease transmission. Nat Biotechnol. 2017;35:1059–68. https://doi.org/10.1038/nbt.3997.
Mojica FJ, Montoliu L. On the origin of CRISPR-Cas technology: from prokaryotes to mammals. Trends Microbiol. 2016;24(10):811–20. https://doi.org/10.1016/j.tim.2016.06.005.
Ma H, et al. Correction of a pathogenic gene mutation in human embryos. Nature. 2017;548:413–9. https://doi.org/10.1038/nature23305.
De Wert G, Heindryckx B, Pennings G, Clarke A, Eichenlaub-Ritter U, van El CG FF, Goddijn M, Howard HC, Radojkovic D, Rial-Sebbag E, Dondorp W, Tarlatzis BC, Cornel MC. Responsible innovation in human germline gene editing. Background document to the recommendations of ESHG and ESHRE. Eur J Hum Genet. 2018;26(4):450–70. https://doi.org/10.1038/s41431-017-0077-z.
Harper JC, Kennett D, Reisel D. The end of donor anonymity: how genetic testing is likely to drive anonymous gamete donation out of business. Hum Reprod. 2016;31:1135–40.
Salama M, Isachenko V, Isachenko E, Rahimi G, Mallmann P, Westphal LM, Inhorn MC, Patrizio P. Cross border reproductive care (CBRC): a growing global phenomenon with multidimensional implications (a systematic and critical review). J Assist Reprod Genet. 2018;35(7):1277–88. [Epub ahead of print].
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mendoza Ladrón de Guevara, N., Motos Guirao, M.A. (2019). Assisted Reproductive Technology in Perimenopausal Women. In: Pérez-López, F. (eds) Postmenopausal Diseases and Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-13936-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-13936-0_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-13935-3
Online ISBN: 978-3-030-13936-0
eBook Packages: MedicineMedicine (R0)